SCHEMBL30749234

SCHEMBL30749234

CC(C)(C)OC(=O)N1CCCCC1c1cc(Cl)ccc1CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ TSHR P16473 4/20 0.52
▸ LMNA P02545 4/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.52
▸ MAPT P10636 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ POLB P06746 1/20 0.43
▸ F2 P00734 2/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ OPRK1 P41145 2/20 0.41
▸ F10 P00742 1/20 0.39
▸ F12 P00748 1/20 0.39
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ F7 P08709 1/20 0.39
▸ PRSS3 P35030 1/20 0.39
▸ USP30 Q70CQ3 2/20 0.39
▸ UCHL1 P09936 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27224081 1.00 ALDH1A1 (0.54) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL30899767 0.97 ALDH1A1 (0.58) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL27223962 0.97 ALDH1A1 (0.58) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL30749382 0.93 ALDH1A1 (0.48) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL30749357 0.84 TSHR (0.46) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL27223611 0.84 TSHR (0.46) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL27224156 0.84 TSHR (0.48) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL27223536 0.83 F2 (0.40) ALDH1A1LMNAMEN1KMT2ANPSR1
SCHEMBL30749316 0.83 ALDH1A1 (0.48) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL27224030 0.83 ALDH1A1 (0.48) ALDH1A1TSHRLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573096-A1 INHIBITORS OF MYELOPEROXIDASE Astrazeneca AB (SE) 2025-06-25 — — EP disclosed
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-05-23 — — US disclosed
WO-2024038131-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE MPO, XDH, EPX ALDH1A1 502/4885TSHR 1871/4885LMNA 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback